SUNNYVALE, Calif., July 19, 2018 /PRNewswire/ -- Accuray
Incorporated (NASDAQ: ARAY) announced today the appointment of
Joseph E. Whitters to the company's
Board of Directors, effective as of July 16,
2018. In addition, he will serve on the Board's Audit
Committee. With Mr. Whitters' appointment, the Accuray Board has
been expanded to eight members.
Mr. Whitters brings significant public company governance
experience in the medical technology and medical device industries
to Accuray. He currently serves on the boards of publicly traded
PRGX Global, Inc. and InfuSystem Holdings, Inc. and his prior
public company board experience includes Analogic Corporation, Air
Methods Corporation, Mentor Worldwide LLC and Omnicell, Inc.
Since 2005, Mr. Whitters has been associated with Frazier
Healthcare Partners, a leading provider of venture and growth
equity capital to emerging healthcare companies. Prior to joining
Frazier, Mr. Whitters held multiple leadership positions at First
Health Group Corporation, a managed care organization, including
Chief Financial Officer.
"Joe's background makes him an ideal candidate for the Accuray
Board as we continue our focus on maximizing shareholder value. His
strong shareholder value orientation and long track record of
shareholder advocacy have been of benefit to other companies where
he has served on the board, and we believe Accuray will likewise
gain from his expertise," said Joshua H.
Levine, President and Chief Executive Officer of
Accuray.
"For the last 15 years, I have served as a board member working
in partnership with other board members and senior management teams
to successfully accelerate their organization's growth and build
shareholder value. I joined the Accuray Board because I believe my
experience can help the company achieve its potential. My
background in the medical device industry has given me an
appreciation for the uniqueness of the Accuray radiation therapy
systems and I believe in the devices' ability to deliver on market
needs over the long term, offering value to patients, customers and
shareholders alike," said Joseph
Whitters.
About Accuray
Accuray Incorporated (NASDAQ: ARAY) is a radiation oncology company
that develops, manufactures, and sells precise, innovative tumor
treatment solutions that set the standard of care with the aim of
helping patients live longer, better lives. The company's
leading-edge technologies deliver the full range of radiation
therapy and radiosurgery treatments. For more information, please
visit www.accuray.com.
Safe Harbor Statement
Statements made in this press release that are not statements of
historical fact are forward-looking statements and are subject to
the "safe harbor" provisions of the Private Securities Litigation
Reform Act of 1995. Forward-looking statements in this press
release relate, but are not limited, to expectations regarding the
company's growth and ability to increase shareholder value. These
forward-looking statements involve risks and uncertainties. If
any of these risks or uncertainties materialize, or if any of the
company's assumptions prove incorrect, actual results could differ
materially from the results expressed or implied by these
forward-looking statements. These risks and uncertainties include,
but are not limited to, the company's ability to achieve widespread
market acceptance of its products, the company's ability to achieve
profitability by maintaining or increasing gross margins on its
products sales and services, the company's ability to anticipate or
keep pace with changes in the marketplace and the direction of
technological innovation and customer demands and such other risks
identified under the heading "Risk Factors" in the company's annual
report on Form 10-K, filed with the Securities and Exchange
Commission (the "SEC") on August 25,
2017, the company's quarterly report on Form 10-Q, filed
with the SEC on May 2, 2018 and as
updated periodically with the company's other filings with the
SEC.
Forward-looking statements speak only as of the date the
statements are made and are based on information available to the
company at the time those statements are made and/or management's
good faith belief as of that time with respect to future events.
The company assumes no obligation to update forward-looking
statements to reflect actual performance or results, changes in
assumptions or changes in other factors affecting forward-looking
information, except to the extent required by applicable securities
laws. Accordingly, investors should not put undue reliance on any
forward-looking statements.
Investor Contact:
Todd Kehrli
EVC Group
+1 (310) 625-4462
tkehrli@evcgroup.com
Media Contact:
Beth
Kaplan
Accuray
+1 (408)
789-4426
bkaplan@accuray.com
View original content with
multimedia:http://www.prnewswire.com/news-releases/joseph-e-whitters-appointed-to-accuray-board-of-directors-300683613.html
SOURCE Accuray Incorporated